Clinical trial
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary…
NCT00293878 · Forbes Medi-Tech, Industry · Completed
Key facts
| NCT number | NCT00293878 |
|---|---|
| Title | Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Effects on Lipids of 12 Weeks of 2 Doses of FM-VP4 in Subjects With Primary Hypercholesterolemia |
| Lead sponsor | Forbes Medi-Tech, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Disodium Ascorbyl Phytostanol Phosphate (FM-VP4) |
| Enrollment | 150 |
| Start date | Nov 1, 2005 |
| First posted | Feb 20, 2006 |
| Last update posted | Feb 26, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: